Abbott Molecular Licenses Affy s CGH Microarray Patents

Apr 05, 2006

NEW YORK, April 5 (GenomeWeb News) - Affymetrix has licensed a number of patents to
Abbott Molecular, a division of Abbott, the company said today.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.